For Immediate Release

ANNOUNCING NEW, NON-TOBACCO, SAFE PRODUCT FOR NON-SMOKING ZONES;

NOVUS TWIGS TARGET NATION’S GROWING SMOKE-FREE ENVIRONMENTS

 Launch Coincides With Annual ‘Great American Smokeout Day’

NEW YORK CITY, NY, November 15, 2012 – Defying cigarettes’ long-term, devastating health effects, one-in-five adult Americans (45 million), especially young people, still smoke, according to the Center for Disease Control and Prevention. This, in spite of the 22,458 municipalities in 39 states, which currently enforce a 100% smoke-free provision in public spaces, an analysis from the American Nonsmokers’ Rights Foundation confirms.

For the huge numbers who still choose to smoke, this often gives rise to troubling productivity and lifestyle issues.  For employees and hospitality managers, keeping smokers and non-smokers satisfied has become a one-sided argument in favor of non-smokers.

Coinciding with the American Cancer Society’s annual “Great American Smokeout Day,” Sentiens, a North Carolina-headquartered research and development company, is launching Novus Twigs, a botanically-based, non-nicotine, tobacco-less cigarette alternative for smokers in no-smoking areas such as restaurants, hotels, office buildings, casinos, airports, clubs, campuses, local parks and residential buildings.

As a safe substitute for cigarettes, Novus Twigs enable smokers to experience the identical satisfactions generated by smoking while in a smoke-free zone.

Odorless, smokeless, tobacco-free and vaporless, Novus Twigs are offensive to no one.  Based on more than 12 years of scientific research, they are a lifestyle solution for smokers and non-smokers alike.  Participants in product development research studies found that they were readily accepted in public spaces.

The new product looks exactly like a cigarette and has been shown to effectively provide immediate smoking pleasure through a proprietary BotanicBoost™ formula.  In product testing studies, smokers were able to enjoy the Novus experience for as long as three hours.

The ingredients in Novus are generally recognized as safe (GRAS) for food use by the FDA.  Since Novus is not a drug, device or tobacco product, it does not require FDA regulatory guidance nor is it subject to the high taxes imposed on cigarettes.   The formula was developed to effectively engage the sensory system associated with cigarette smoking.  The product as noted, is smokeless and vaporless and unlike e-cigarettes, requires no chargers or other paraphernalia.

Novus Twigs will come in five flavors — smooth, citrus, mint, lemon, and coming soon full flavor.  Each is the equivalent of two or three cigarettes.  Suggested retail cost for a single Novus is:  $0.99   Novus Twigs will be sold wherever smoking products are sold, as well as online at www.novus1.com.   Novus is not recommended for sale to minors under 18 years of age.

Not an e-cigarette or a specifically cessation product, Novus Twigs were developed by a Sentiens team of scientists and addiction specialists.  The product delivers a smoking sensation through a combination of sensory stimuli – from the outer white wrap to the inner paper to the all-natural botanic formula itself – without the socially unacceptable side effects of second-hand smoke, odor and ashes.

Unique BotanicBoost™ Boost Formula

Novus claims a uniquely designed formula of natural flavors, spices and botanical tinctures that work together to mimic the key features of a cigarette without delivering nicotine or other toxic and carcinogenic materials.

“BotanicBoost™ is a proprietary platform technology that focuses on a deep understanding of how the human body functions, particularly how the body’s nervous system acts as a primary pathway for our initial reaction to our environment and to the body’s response to those stimuli,” stated Dennis Tan, Co-Founder of Sentiens and one of the developers of Novus . “This is an underappreciated and unexploited area of research,” he continued.

About Sentiens LLC

Sentiens LLC, (www.sentiens.us) based in North Carolina, is a research and development company that is focused on designing products that can have a positive impact on society through improving health and wellness.  The emphasis of the company’s science is targeting known addictive behaviors with nutraceutical products that utilize proprietary technology platforms, and leverage the company’s expertise in systemic sensory pathways.

Contact:          Janet Bartucci

The Dilenschneider Group

212 922-0900

jbartucci@dgi-nyc.com

# # #